chemotherapy
Investigators from Atrium Health recently published a study comparing pretreatment and posttreatment testing, showing a strong benefit in a real-world clinical cohort.
Polygenic Score May Help Personalize Induction Chemo, Improve Black Pediatric AML Patients' Outcomes
At ASH, researchers reported that a PGx-based score could identify the cytarabine-based induction therapy young Black patients are most likely to benefit from.
Novacyt Secures IVDR Certification for Genetic Chemotoxicity Test
The assay is designed to identify cancer patients with an enzyme deficiency that can cause dangerous side effects from 5-fluorouracil treatment.
Lung Cancer Treatment Response, Outcomes Linked to Liquid Biopsy Profiles
An unresectable, locally advanced non-small cell lung cancer study highlighted molecular residual disease patterns associated with chemoradiation response and survival outcomes.
Cell-Free DNA Shows Promise as Cardiotoxicity Biomarker in HER2-Positive Breast Cancer Patients
The findings, published in JAMA Cardiology, show the role of cardiomyocyte-derived cell free DNA in predicting risk of post-chemotherapy cardiac problems.